» Articles » PMID: 28306714

Reconstruction and Signal Propagation Analysis of the Syk Signaling Network in Breast Cancer Cells

Overview
Specialty Biology
Date 2017 Mar 18
PMID 28306714
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The ability to build in-depth cell signaling networks from vast experimental data is a key objective of computational biology. The spleen tyrosine kinase (Syk) protein, a well-characterized key player in immune cell signaling, was surprisingly first shown by our group to exhibit an onco-suppressive function in mammary epithelial cells and corroborated by many other studies, but the molecular mechanisms of this function remain largely unsolved. Based on existing proteomic data, we report here the generation of an interaction-based network of signaling pathways controlled by Syk in breast cancer cells. Pathway enrichment of the Syk targets previously identified by quantitative phospho-proteomics indicated that Syk is engaged in cell adhesion, motility, growth and death. Using the components and interactions of these pathways, we bootstrapped the reconstruction of a comprehensive network covering Syk signaling in breast cancer cells. To generate in silico hypotheses on Syk signaling propagation, we developed a method allowing to rank paths between Syk and its targets. We first annotated the network according to experimental datasets. We then combined shortest path computation with random walk processes to estimate the importance of individual interactions and selected biologically relevant pathways in the network. Molecular and cell biology experiments allowed to distinguish candidate mechanisms that underlie the impact of Syk on the regulation of cortactin and ezrin, both involved in actin-mediated cell adhesion and motility. The Syk network was further completed with the results of our biological validation experiments. The resulting Syk signaling sub-networks can be explored via an online visualization platform.

Citing Articles

Epigenetic Mechanisms of Endocrine-Disrupting Chemicals in Breast Cancer and Their Impact on Dietary Intake.

Singh D J Xenobiot. 2025; 15(1.

PMID: 39846533 PMC: 11755457. DOI: 10.3390/jox15010001.


Comparison of SYK Signaling Networks Reveals the Potential Molecular Determinants of Its Tumor-Promoting and Suppressing Functions.

Buffard M, Naldi A, Freiss G, Deckert M, Radulescu O, Coopman P Biomolecules. 2021; 11(2).

PMID: 33670716 PMC: 7923165. DOI: 10.3390/biom11020308.


EEG Signal Reconstruction Using a Generative Adversarial Network With Wasserstein Distance and Temporal-Spatial-Frequency Loss.

Luo T, Fan Y, Chen L, Guo G, Zhou C Front Neuroinform. 2020; 14:15.

PMID: 32425763 PMC: 7204859. DOI: 10.3389/fninf.2020.00015.


cAMP- and cGMP-elevating agents inhibit GPIbα-mediated aggregation but not GPIbα-stimulated Syk activation in human platelets.

Makhoul S, Trabold K, Gambaryan S, Tenzer S, Pillitteri D, Walter U Cell Commun Signal. 2019; 17(1):122.

PMID: 31519182 PMC: 6743169. DOI: 10.1186/s12964-019-0428-1.


expression level distinguishes control from -mutated lymphocytes.

Zahavi T, Sonnenblick A, Shimshon Y, Kadouri L, Peretz T, Salmon A Cancer Manag Res. 2018; 10:589-598.

PMID: 29618939 PMC: 5875411. DOI: 10.2147/CMAR.S156359.


References
1.
Larive R, Urbach S, Poncet J, Jouin P, Mascre G, Sahuquet A . Phosphoproteomic analysis of Syk kinase signaling in human cancer cells reveals its role in cell-cell adhesion. Oncogene. 2009; 28(24):2337-47. DOI: 10.1038/onc.2009.99. View

2.
Blancato J, Graves A, Rashidi B, Moroni M, Tchobe L, Ozdemirli M . SYK allelic loss and the role of Syk-regulated genes in breast cancer survival. PLoS One. 2014; 9(2):e87610. PMC: 3921124. DOI: 10.1371/journal.pone.0087610. View

3.
Subramanian A, Tamayo P, Mootha V, Mukherjee S, Ebert B, Gillette M . Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005; 102(43):15545-50. PMC: 1239896. DOI: 10.1073/pnas.0506580102. View

4.
Toyama T, Iwase H, Yamashita H, Hara Y, Omoto Y, Sugiura H . Reduced expression of the Syk gene is correlated with poor prognosis in human breast cancer. Cancer Lett. 2002; 189(1):97-102. DOI: 10.1016/s0304-3835(02)00463-9. View

5.
Turner M, Mee P, Costello P, Williams O, Price A, Duddy L . Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature. 1995; 378(6554):298-302. DOI: 10.1038/378298a0. View